FDA Inspection 1036885 — ACM Global Laboratories
The FDA completed an inspection of ACM Global Laboratories on Dec 7, 2017 in Rochester, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 7, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rochester, NY (United States)
Additional Details
Sponsor, Contract Research Organization